A Phase I study with an anti-CD30 ricin A-chain immunotoxin (Ki-4.dgA) in patients with refractory CD30+ Hodgkin’s and non-Hodgkin’s lymphoma - Schnell, R; Staak, JO; Borchmann, P (Clin Cancer Res, 2002)